Bernzott Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.63M Sell
22,152
-8,242
-27% -$1.92M 2.25% 19
2026
Q1
$7.43M Sell
30,394
-2,176
-7% -$507K 3.56% 6
2025
Q4
$6.74M Sell
32,570
-699
-2% -$138K 3.21% 16
2025
Q3
$6.17M Sell
33,269
-133
-0.4% -$22.8K 2.91% 21
2025
Q2
$5.1M Sell
33,402
-1,079
-3% -$166K 2.6% 25
2025
Q1
$5.72M Sell
34,481
-1,314
-4% -$206K 2.82% 21
2024
Q4
$5.18M Sell
35,795
-3,528
-9% -$547K 2.56% 24
2024
Q3
$6.37M Sell
39,323
-58
-0.1% -$9.24K 2.74% 20
2024
Q2
$5.76M Sell
39,381
-4,767
-11% -$709K 2.65% 25
2024
Q1
$6.98M Buy
44,148
+2,434
+6% +$387K 2.76% 25
2023
Q4
$6.54M Sell
41,714
-561
-1% -$86K 2.55% 21
2023
Q3
$6.58M Sell
42,275
-6,232
-13% -$1.03M 2.27% 24
2023
Q2
$8.03M Sell
48,507
-1,365
-3% -$220K 1.73% 27
2023
Q1
$7.73M Sell
49,872
-12,679
-20% -$2.05M 1.6% 35
2022
Q4
$11M Buy
62,551
+1,433
+2% +$247K 1.43% 33
2022
Q3
$9.98M Sell
61,118
-461
-0.7% -$78K 1.38% 32
2022
Q2
$10.9M Sell
61,579
-2,870
-4% -$511K 1.21% 34
2022
Q1
$11.4M Sell
64,449
-1,017
-2% -$173K 1.05% 35
2021
Q4
$11.2M Sell
65,466
-4,432
-6% -$726K 0.97% 35
2021
Q3
$11.3M Buy
69,898
+1,585
+2% +$270K 1.02% 37
2021
Q2
$11.3M Buy
68,313
+1,307
+2% +$216K 0.95% 35
2021
Q1
$11M Sell
67,006
-6,259
-9% -$1.01M 0.97% 33
2020
Q4
$11.5M Sell
73,265
-6,522
-8% -$962K 1.04% 32
2020
Q3
$11.9M Buy
79,787
+6,238
+8% +$923K 1.13% 28
2020
Q2
$10.3M Sell
73,549
-2,018
-3% -$294K 1.3% 30
2020
Q1
$9.91M Sell
75,567
-7,763
-9% -$1.1M 1.53% 28
2019
Q4
$12.2M Buy
83,330
+6,198
+8% +$841K 1.27% 31
2019
Q3
$9.98M Buy
77,132
+1,000
+1% +$132K 1.19% 32
2019
Q2
$10.6M Sell
76,132
-1,576
-2% -$218K 1.28% 32
2019
Q1
$10.9M Buy
77,708
+2,430
+3% +$325K 1.31% 33
2018
Q4
$9.71M Sell
75,278
-7
-0% -$976 1.36% 34
2018
Q3
$10.4M Buy
75,285
+200
+0.3% +$26.6K 1.2% 33
2018
Q2
$9.11M Buy
75,085
+5,490
+8% +$685K 1.13% 32
2018
Q1
$8.92M Sell
69,595
-1,405
-2% -$190K 1.16% 30
2017
Q4
$9.92M Buy
71,000
+8,775
+14% +$1.22M 1.31% 28
2017
Q3
$8.09M Sell
62,225
-1,495
-2% -$198K 1.15% 29
2017
Q2
$8.43M Sell
63,720
-549
-0.9% -$70K 1.39% 28
2017
Q1
$8.01M Sell
64,269
-1,125
-2% -$134K 1.38% 28
2016
Q4
$7.53M Buy
65,394
+2,270
+4% +$262K 1.28% 29
2016
Q3
$7.46M Sell
63,124
-15,630
-20% -$1.9M 1.38% 28
2016
Q2
$9.55M Sell
78,754
-1,900
-2% -$216K 1.86% 27
2016
Q1
$8.73M Sell
80,654
-3,922
-5% -$406K 1.66% 27
2015
Q4
$8.69M Buy
84,576
+1,176
+1% +$118K 1.69% 28
2015
Q3
$7.79M Buy
83,400
+266
+0.3% +$25.7K 1.79% 25
2015
Q2
$8.1M Buy
83,134
+35,405
+74% +$3.55M 1.74% 27
2015
Q1
$4.8M Sell
47,729
-3,310
-6% -$337K 1.07% 31
2014
Q4
$5.34M Sell
51,039
-610
-1% -$64.3K 1.16% 34
2014
Q3
$5.5M Sell
51,649
-101
-0.2% -$10.5K 1.29% 32
2014
Q2
$5.41M Sell
51,750
-320
-0.6% -$32.3K 1.24% 32
2014
Q1
$5.12M Buy
52,070
+1,075
+2% +$99.7K 1.22% 32
2013
Q4
$4.67M Buy
50,995
+45
+0.1% +$4.15K 1.06% 35
2013
Q3
$4.42M Sell
50,950
-351
-0.7% -$31.5K 1.11% 36
2013
Q2
$4.41M Buy
+51,301
New +$4.35M 1.21% 35

Other funds holding JNJ

Bernzott Capital Advisors's JNJ Position: Q2 2026 in Review

Bernzott Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, selling an estimated $1.92M and leaving 22,152 shares worth $5.63M. The position accounts for 2.25% of the portfolio, ranked #19.

Bernzott Capital Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.2M in Q4 2019. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bernzott Capital Advisors held 22,152 shares of Johnson & Johnson worth $5.63M as of Q2 2026.
  • Bernzott Capital Advisors sold 8,242 Johnson & Johnson shares in Q2 2026, an estimated $1.92M.
  • Johnson & Johnson made up 2.25% of Bernzott Capital Advisors's portfolio in Q2 2026, its #19 holding.
  • Bernzott Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Bernzott Capital Advisors's Johnson & Johnson position peaked at $12.2M in Q4 2019.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bernzott Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.